LONDON, ONTARIO--(MARKET WIRE)--Jun 26, 2007 -- Critical Outcome Technologies Inc. (CDNX:COT.V - News), announced today that it received a proposal from 6441513 Canada Inc. operating as DDP Therapeutics (DDP), a Canadian private corporation, for the purchase by Critical Outcome Technologies Inc. (COTI) of the 90% share ownership of DDP not currently owned by COTI.
